A Case of Anaphylactic Response to Factor lX Replacement Therapy in Hemophilia B Patient / 대한혈액학회지
Korean Journal of Hematology
; : 188-190, 2003.
Article
in Ko
| WPRIM
| ID: wpr-720471
Responsible library:
WPRO
ABSTRACT
We report a first korean case of anaphylactic response to factor lX replacement therapy in 22-month-old male hemophilia B patient. He was admitted to our hospital via emergency room due to anaphylactic response after factor lX infusion. Immediately after the infusion, he became dyspneic and cyanotic. The symptoms completely resolved after sleep. He represented same symptoms after next factor lX infusion, which completely resolved by the administration of oxygen. At the time of anaphylaxis, inhibitors of factor lX was demonstrated(8.8 Bethesda Unit). We planned him to treat with recombinant factor Vll or diluted factor lX at bleeding episode.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Oxygen
/
Hemophilia B
/
Emergency Service, Hospital
/
Hemophilia A
/
Hemorrhage
/
Anaphylaxis
Limits:
Humans
/
Infant
/
Male
Language:
Ko
Journal:
Korean Journal of Hematology
Year:
2003
Type:
Article